| The 4th of July is a holiday in the U.S. that celebrates the signing of the Declaration of Independence on July 4, 1776. Thanks to this historic event and the freedoms it protects, many types of innovation have flourished over the past 243 years.
In honor of this day, BioInformant is celebrating advances in Regenerative Medicine (RM) and how this industry will change healthcare as we know it.
Regenerative medicine companies are now emerging every single week, which is why BioInformant maintains the world’s only searchable, sortable database of regenerative medicine companies worldwide that is continuously updated on a daily basis.
The latest addition to the Regenerative Medicine Industry is Century Therapeutics. With rights to a revolutionary induced pluripotent stem cell (iPSC) allogeneic cell therapy platform, the company was created by Versant Ventures. It emerged from stealth mode on July 1, 2019, with $250M in financing from Bayer, Versant and Fujifilm Cellular Dynamics Inc. (FCDI).
With a mission to produce vast amounts of allogeneic, homogeneous iPSC-derived cellular therapeutics, Century Therapeutics has the potential to dramatically impact the Regenerative Medicine Industry.
Claim it now to get 50% Off and Free Updates for the next 12 Months:
|
